About lab
Orton2009 - Modelling cancerous mutations inthe EGFR/ERK pathway - EGF Model This model studies the aberrations inERK signalling for different cancer mutations. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packageorton2009-modelling-cancerous-mutations-in-the-egfr-erk-pathway
Created2026-05-16
Updated2026-05-16
biomodels_ebicurateddrug-responsefaithfuloncologypharmacologyphysiologysbmlsignal-transductionsignalingsystemsbiologytumor-growthvisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "initial_free_egfreceptor",
"label": "FreeEGFReceptor",
"units": "native SBML value",
"default": 80000,
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.initial_free_egfreceptor",
"description": "Initial FreeEGFReceptor. Sets the initial value of bundled SBML symbol `species_1`."
},
{
"name": "initial_bound_egfreceptor",
"label": "BoundEGFReceptor",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.initial_bound_egfreceptor",
"description": "Initial BoundEGFReceptor. Sets the initial value of bundled SBML symbol `species_0`."
},
{
"name": "initial_degraded_egfreceptor",
"label": "DegradedEGFReceptor",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.initial_degraded_egfreceptor",
"description": "Initial DegradedEGFReceptor. Sets the initial value of bundled SBML symbol `species_18`."
},
{
"name": "initial_ras_inactive",
"label": "RasInactive",
"units": "native SBML value",
"default": 120000,
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.initial_ras_inactive",
"description": "Initial RasInactive. Sets the initial value of bundled SBML symbol `species_5`."
},
{
"name": "initial_raf1_inactive",
"label": "Raf1Inactive",
"units": "native SBML value",
"default": 120000,
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.initial_raf1_inactive",
"description": "Initial Raf1Inactive. Sets the initial value of bundled SBML symbol `species_7`."
},
{
"name": "initial_erk_inactive",
"label": "ErkInactive",
"units": "native SBML value",
"default": 600000,
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.initial_erk_inactive",
"description": "Initial ErkInactive. Sets the initial value of bundled SBML symbol `species_11`."
}
],
"outputs": [
{
"name": "free_egfreceptor",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.free_egfreceptor",
"description": "FreeEGFReceptor observable. Maps to SBML symbol `species_1`."
},
{
"name": "bound_egfreceptor",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.bound_egfreceptor",
"description": "BoundEGFReceptor observable. Maps to SBML symbol `species_0`."
},
{
"name": "degraded_egfreceptor",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.degraded_egfreceptor",
"description": "DegradedEGFReceptor observable. Maps to SBML symbol `species_18`."
},
{
"name": "ras_inactive",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.ras_inactive",
"description": "RasInactive observable. Maps to SBML symbol `species_5`."
},
{
"name": "raf1_inactive",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.raf1_inactive",
"description": "Raf1Inactive observable. Maps to SBML symbol `species_7`."
},
{
"name": "erk_inactive",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.erk_inactive",
"description": "ErkInactive observable. Maps to SBML symbol `species_11`."
},
{
"name": "state",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"oncology",
"pharmacology",
"physiology",
"sbml",
"signal-transduction",
"signaling",
"systemsbiology",
"tumor-growth"
],
"title": "Orton2009 - Modelling cancerous mutations in the EGFR/ERK pathway - EGF Model Lab",
"models": [
{
"path": "owned/models/oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model",
"alias": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model",
"provenance": {
"owned_path": "owned/models/oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model_state"
],
"from": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.state"
},
{
"to": [
"visualisation.oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model_summary"
],
"from": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model_species_labels"
],
"from": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.species_labels"
}
],
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"description": "Orton2009 - Modelling cancerous mutations inthe EGFR/ERK pathway - EGF Model This model studies the aberrations inERK signalling for different cancer mutations. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.